Use of recombinant human erythropoietin in kidney transplant patients with stable graft function

Transplantation Proceedings

Volumn 35, Issue 5, 2003, Pages 1767-1768

  Ortiz, F ^a,b   Guirado, L ^a   Diaz J ^a   Garcia Trabanino R ^a   Garra, N ^a   Sainz Z ^a   Picazo, M ^a   Garcia R M ^a   Alcaraz, A ^a   Sola R ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b FUNDACIÓ PUIGVERT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; RECOMBINANT ERYTHROPOIETIN;

ANTHROPOMETRIC PARAMETERS; BLOOD PRESSURE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DONOR; ERYTHROCYTE; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEINURIA; RECIPIENT;

EID: 10744230876     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00732-2     Document Type: Conference Paper

References (8)

1. Muirhead N. Kidney Int. 55:1999;S86.
2. Moore L., Smith S., Winsett R., et al. Clin Transplant. 8:1994;358.
3. Ettenger R.B., Marik J., Grimm P. Am J Kidney Dis. 18:(4 Suppl 1):1991;57.
4. Van Loo A., Vanholder R., Bernaert P., et al. Nephrol Dial Transplant. 11:1996;1815.
5. Beshara S., Birgegard G., Goch J., et al. Eur J Haematol. 58:1997;167.
6. Ortega F., Baltar J., Rebollo P., et al. Nefrología. 19:(S3):1999;34.
7. Montanaro D., Gropuzzo M., Tulissi P., et al. Transplant Proc. 33:2001;2038.
8. Morales J., Vanrentergherm Y., Abramowicz D., et al. Nefrología. 21:(S2):2001;78.